TY - JOUR T1 - Epidemiology of pediatric cancer in the Northwest Region of Cameroon JF - medRxiv DO - 10.1101/2020.02.04.20020487 SP - 2020.02.04.20020487 AU - Rohit Borah AU - Francine Kouya Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/06/2020.02.04.20020487.abstract N2 - Background The epidemiological scale of cancer in Cameroon is still relatively unknown, as public health research in sub-Saharan Africa has traditionally focused on infectious and/or communicable disease. As awareness for chronic disease such as cancer has risen, so, too, have diagnoses and incidence. In order to ensure more effective care and quality of life for children at greater risk for cancer diagnoses, specific and effective research must be conducted in order to institute effective policy and protocols.Objective To comprehensively review all pediatric cancer cases seen in the Northwest Region of Cameroon in order to provide novel, current epidemiological data on pediatric cancer in the region.Methods The authors retrospectively reviewed each individual pediatric cancer case seen from January 1, 2016, through November 30, 2017, in the three largest hospitals in the Northwest Region of Cameroon: Mbingo Baptist Hospital, Bamenda Provincial Hospital, and Banso Baptist Hospital.Results 173 cases of pediatric cancer were identified as being treated in one of the three hospitals in question over the 25-month study period. The average age of the patients was 6.23 years (SD = ± 3.93), and 58.4% of the patients were male. The three most common types of cancer diagnosed in these pediatric patients were Burkitt lymphoma, retinoblastoma, and Wilms tumor. Of the 173 cases, 105 of the patients were originally from the Northwest Region. The incidence of pediatric cancer originating from the Northwest Region of Cameroon is 5.92 cases (95% CI: 4.79 – 7.05) per 100,000 persons per year.Conclusion This study is the first extensive examination of pediatric cancer epidemiology in the Northwest Region of Cameroon. Children in sub-Saharan Africa are disproportionately affected by cancer in comparison with their counterparts in the developed world. As the body of literature continues to grow in the years to come, more effective care both preventive and curative can affect the lives of millions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the Cameroon Baptist Convention and associated physicians.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data available upon request. ER -